相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways
Thiago Bruder-Nascimento et al.
CLINICAL SCIENCE (2015)
Mineralocorticoid receptor blockade prevents vascular remodelling in a rodent model of type 2 diabetes mellitus
Marcondes Alves B. Silva et al.
CLINICAL SCIENCE (2015)
Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
Rajesh Garg et al.
DIABETES (2015)
Anthocyanin increases adiponectin secretion and protects against diabetes-related endothelial dysfunction
Yan Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
New insights into insulin action and resistance in the vasculature
Camila Manrique et al.
YEAR IN DIABETES AND OBESITY (2014)
Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes
Bainian Chen et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers
Krzysztof Labuzek et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells
Xiaolu Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
Thiago Bruder-Nascimento et al.
DIABETOLOGY & METABOLIC SYNDROME (2014)
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment
Goodarz Danaei et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Boldine improves endothelial function in diabetic db/db mice through inhibition of angiotensin II-mediated BMP4-oxidative stress cascade
Yeh Siang Lau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications
Noboru Toda et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes
Gopal V. Velmurugan et al.
CARDIOVASCULAR RESEARCH (2013)
Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis
Nancy J. Brown
NATURE REVIEWS NEPHROLOGY (2013)
Aldosterone Induces Vascular Insulin Resistance by Increasing Insulin-Like Growth Factor-1 Receptor and Hybrid Receptor
Shamshad J. Sherajee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Extrarenal effects of aldosterone
Aurelie Nguyen Dinh Cat et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Aldosterone, Mineralocorticoid Receptor and the Metabolic Syndrome: Role of the Mineralocorticoid Receptor Antagonists
Vanessa Ronconi et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases
Bhoomika M. Patel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways Implications in Diabetes Mellitus-Associated Obesity and Vascular Dysfunction
Ana M. Briones et al.
HYPERTENSION (2012)
Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report
Markus Resch et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR
Glaucia E. Callera et al.
CARDIOVASCULAR RESEARCH (2011)
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Johannes-Peter Stasch et al.
CIRCULATION (2011)
Aldosterone Blockers (Mineralocorticoid Receptor Antagonism) and Potassium-Sparing Diuretics
Murray Epstein et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
Menage a trois: Aldosterone, sodium and nitric oxide in vascular endothelium
Johannes Fels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Potassium softens vascular endothelium and increases nitric oxide release
H. Oberleithner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
Philip Wenzel et al.
ATHEROSCLEROSIS (2008)
Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men
Fabian Nietlispach et al.
HYPERTENSION (2007)
Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone
Juan M. Mejia-Vilet et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-β and NADPH oxidase in the hypertensive kidney
Maristela Lika Onozato et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice
Malarvannan Pannirselvam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels
Johannes-Peter Stasch et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity
Daisuke Nagata et al.
HYPERTENSION (2006)
Role of nitric oxide and endothelium-derived hyperpolarizing factor (EDHF) in the regulation of blood pressure by leptin in lean and obese rats
Jerzy Beltowski et al.
LIFE SCIENCES (2006)
Endothelial nitric oxide synthase in vascular disease -: From marvel to menace
U Förstermann et al.
CIRCULATION (2006)
Two distinct pathways account for EDHF-dependent dilatation in the gracilis artery of dyslipidaemic hApoB+/+ mice
S Krummen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src
GE Callera et al.
HYPERTENSION (2005)
Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels
L Michea et al.
ENDOCRINOLOGY (2005)
Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice - Key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo
RS Scotland et al.
CIRCULATION (2005)
Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo
SE Wolfle et al.
JOURNAL OF VASCULAR RESEARCH (2005)
Plasma aldosterone concentration in the patient with diabetes mellitus
NK Hollenberg et al.
KIDNEY INTERNATIONAL (2004)
Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease
RM Touyz
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2004)
Rapid nongenomic effects of aldosterone on human forearm vasculature
BMW Schmidt et al.
HYPERTENSION (2003)
Aldosterone induces contraction of the resistance arteries in man
P Romagni et al.
ATHEROSCLEROSIS (2003)
Spironolactone improves angiotensin-induced vascular changes and oxidative stress
A Virdis et al.
HYPERTENSION (2002)
Global and societal implications of the diabetes epidemic
P Zimmet et al.
NATURE (2001)
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus
T Heitzer et al.
DIABETOLOGIA (2000)
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice
RP Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase
H Ding et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure
CAJ Farquharson et al.
CIRCULATION (2000)
分享论文
